NCT06179771View on ClinicalTrials.gov

Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
Acute Kidney InjuryARDSInflammationExtracorporeal Circulation; Complications
Interventions
DEVICE

HA 380

HA380 hemoperfusion cartridge is filled with neutral macroporous resin, mainly adsorbing molecules from 10 to 60 kDa. Because of the accurate 3D macroporous structure and over 54000 m2 adsorption surface area of the resin. The cartridge is attached to the extracorporeal circuit in series with the oxygenator/ filter of the extracorporeal circuit.

Trial Locations (1)

LE3 9QP

RECRUITING

University Hospitals of Leicester NHS Trust, Leicester

All Listed Sponsors
collaborator

Jafron Biomedical Company Limited

UNKNOWN

lead

University Hospitals, Leicester

OTHER